Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Gisadenafil

Generic Name: Gisadenafil

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₃₃N_₇O_₅S

CAS Number: 334826-98-1

Unique Ingredient Identifier: S6G4R7DI1C

Overview

Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

Background

Gisadenafil has been investigated for the treatment of Prostatic Hyperplasia.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

Phase 2

Completed

Posted: 2007/05/28

Sponsor:Pfizer

ID:NCT00479505

Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.

Phase 2

Completed

Posted: 2007/04/06

Sponsor:Pfizer

ID:NCT00457457

Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

Phase 2

Completed

Posted: 2006/12/08

Sponsor:Pfizer

ID:NCT00408954

A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Phase 1

Completed

Posted: 2005/09/13

Sponsor:Pfizer

ID:NCT00163098

Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction

Phase 2

Completed

Posted: 2005/09/01

Sponsor:Pfizer

ID:NCT00141349

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy